ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

NIH, NCI Being Discussions With HCFA On Reimbursement

April 26, 1996

In Brief: Larry Kun Was Named Clinical Director and Executive Vice President of St. Jude Children’s Research Hospital

November 1, 2013

NCI-Approved Clinical Trials

December 30, 2005

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

June 27, 1986

Bushes Restate Commitment to Dialogue

August 8, 2003

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992